ED
MPT

Exane Derivatives’s Medical Properties Trust MPT Stock Holding History

Exane Derivatives’s Portfolio MPT Stock Details MPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$137 Sell
9
-1,472
-99% -$26.5K ﹤0.01% 703
2022
Q1 		$31.3K Sell
1,481
-267
-15% -$5.75K 0.01% 623
2021
Q4 		$41.3K Buy
1,748
+1,476
+543% +$31.6K 0.01% 515
2021
Q3 		$5.46K Buy
272
+216
+386% +$4.43K ﹤0.01% 730
2021
Q2 		$1.12K Buy
+56
New +$1.2K ﹤0.01% 862
2021
Q1 		– Sell
-5,803
Closed -$126K – 960
2020
Q4 		$126K Buy
+5,803
New +$113K 0.04% 365

Other funds holding MPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIM
Centersquare Investment Management Conshohocken, Pennsylvania $9.67B AUM 5.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

Exane Derivatives's MPT Position: Q2 2022 in Review

Exane Derivatives reduced its Medical Properties Trust (MPT) stake by 99% in Q2 2022, selling an estimated $26.5K and leaving 9 shares worth $137. The position accounts for ﹤0.01% of the portfolio, ranked #703.

Exane Derivatives first reported a position in MPT in Q4 2020 and has held it in 6 quarters since. The position peaked at $126K in Q4 2020. 605 funds tracked by Wall St. Rank hold MPT as of Q2 2022.

  • Exane Derivatives held 9 shares of Medical Properties Trust worth $137 as of Q2 2022.
  • Exane Derivatives sold 1,472 Medical Properties Trust shares in Q2 2022, an estimated $26.5K.
  • Medical Properties Trust made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #703 holding.
  • Exane Derivatives first reported a position in Medical Properties Trust in Q4 2020 and has held it in 6 quarters since.
  • Exane Derivatives's Medical Properties Trust position peaked at $126K in Q4 2020.
  • 605 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.